Private Equity
Reflections on the M&A scene from VCJ’s Venture Alpha conference in October
3 min read · 29 October 2012
Zappos CEO Tony Hsieh is endeavoring to do something more ambitious than ever before. He’s trying to transform 1.5 miles of arid, dust-caked downtown Las Vegas into a bustling entrepreneurial center with up to $350 million of his own money. The question is whether he can pull it off without someone to simply say, “no.”
4 min read · 25 October 2012
Benchmark Capital General Partner Bill Gurley gives a high-energy presentation at VCJ’s Venture Alpha 2012 conference.
1 min read · 24 October 2012
Lerer Ventures said it has raised a $36 million third fund to continue making seed investments in New York and Silicon Valley. The new fund is a noticeable step up from the firm’s $25 million second fund from 2011 and will enable Lerer to take larger positions in portfolio companies.
2 min read · 24 October 2012
There’s little question that on November 6, tech titans will be on tenterhooks as they watch the presidential election results. For one thing, who wins may determine whether today’s laws around repatriation -- bringing overseas earnings back to the U.S. -- will meaningfully change.
4 min read · 24 October 2012
In a victory for Thomson Reuters, a state judge tentatively ruled that the University of California must try to obtain and then disclose closely guarded information on the investment performance of VC funds managed by Kleiner Perkins Caufield & Byers and Sequoia Capital.
4 min read · 24 October 2012
Apple Inc will begin to sell an 8-inch version of the iPad on Friday to compete with smaller tablets including Amazon.com Inc's Kindle, but set a higher-than-expected price tag of $329 that Wall Street fears could curb demand.
5 min read · 23 October 2012
If there is good news to be had in private equity these days it is that limited partners seem to want to put new money to work. Many GPs will argue that consistency is their forte. But only some can truly make that claim, a new study finds.
2 min read · 23 October 2012
The Benchmark General Partner tells LPs at VCJ’s Venture Alpha conference that there are a number of brights spots in the VC industry, but he’s worried that they didn’t learn to be wary of funds in excess of $1 billion.
4 min read · 23 October 2012
Life sciences investor Longitude Capital, which backs drug developers and medical devices, raises $385M for second fund
2 min read · 22 October 2012
